CP122830710 | New Brunswick reports blood clot death in connection with Oxford-AstraZeneca vaccine

CP122904771 | B.C. records first case of rare blood clot related to vaccine

CP122017117 | AstraZeneca blood clot risk remains low: Tam

CP123262421 | N.S. pauses use of AstraZeneca vaccine

CP121635062 | AstraZeneca vaccine to remain authorized in Canada

CP120476771 | AstraZeneca vaccine's benefits vastly outweigh risks: Sharma

CP121946460 | Newly eligible people receive Oxford-AstraZeneca vaccine

CP121584821 | Canada probing J&J vaccine blood-clot reports

CP121955660 | Quebec to start offering Oxford-AstraZeneca vaccine to people 45 and over

CP122094921 | Probe after blood clot death linked to vaccine

Placeline/People

City Vaughan

Country Canada

Quebec reports first blood clot death in woman who received AstraZeneca vaccine

Quebec health officials say the first blood clot death in a woman who received Oxford-AstraZeneca won't change vaccine strategy. Quebec confirms a woman in her 50s has died after receiving the Oxford-AstraZeneca COVID-19 vaccine. The province is currently offering the shot to Quebecers 45 and up.

Source name:

Unique identifier: CP122404571

Legacy Identifier: n_Quebec-Vaccine-Death20210427T1650

Type: Video

Duration: 2m52s

Dimensions: 1920px × 1080px 183.87 MB

Usage rights: FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE.

Create Date: 4/27/2021 4:50:00 PM

Display aspect ratio: 16:9